← All trials
NCT00694798
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2008
- Primary completion
- Jul 1, 2011
- Completion date
- Jul 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 22
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Cadila HealthcareLead sponsor
- Indira Gandhi Medical CollegeOverall official - principal investigator
- Muljibhai Patel Urological HospitalOverall official - principal investigator
- Choithram Hospital and Research CentreOverall official - principal investigator
- Siddhi Vinayak HospitalOverall official - principal investigator
- Excel HospitalOverall official - principal investigator
- Urocare HospitalOverall official - principal investigator
- Desai Urological and Maternity HospitalOverall official - principal investigator
- Aarogyam Speciality HospitalOverall official - principal investigator
- Vardhman Mahavir Medical CollegeOverall official - principal investigator
- Postgraduate Institute of Medical Education and ResearchOverall official - principal investigator
- Lourdes HospitalOverall official - principal investigator
- Institute of Post Graduate Medical Education & ResearchOverall official - principal investigator
- SP Medical College, BikanerOverall official - principal investigator
- Christian Medical College, Vellore, IndiaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.